Literature DB >> 8770691

Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.

S Ish-Shalom1, L G Rao, M A Levine, D Fraser, S W Kooh, R G Josse, R McBroom, M M Wong, T M Murray.   

Abstract

Pseudohypoparathyroidism (PHP) is characterized by a lack of response to parathyroid hormone (PTH); however, normal skeletal responsiveness to PTH in some patients with PHP type Ia was previously suggested on the basis of clinical observations. To test this hypothesis, we measured cyclic adenosine monophosphate (cAMP) production in response to various agonists in bone-derived osteoblast-like (OBL) cells from trabecular explants obtained from an iliac crest biopsy of a 25-year-old woman with PHP. The patient was proved to have PHP type Ia on the basis of Albright's hereditary osteodystrophy and decreased activity of stimulatory guanine nucleotide-binding protein (Gs) in erythrocytes. Responsiveness of the patient's OBL cells was compared with OBL cells from eight subjects aged 18-39 years who had no evidence of metabolic bone disease. OBL cells from the patient responded to the following agonists (expressed in multiples of elevation of cAMP, stimulated/basal, mean +/- SE, n = 3): PTH, 3.8 +/- 0.3; forskolin, 8.2 +/- 0.2; and cholera toxin, 56.8 +/- 10.0. These responses were not significantly different from those of control OBL cells: PTH, 4.5 +/- 1.1 (range 2.4-7.5); forskolin, 7.7 +/- 1.4; and cholera toxin, 57.9 +/- 16.2. The normal cholera toxin response indicated the presence of functional Gs. Bone cells from patients with PHP type Ia may exhibit a normal PTH receptor-coupled adenylyl cyclase system in vitro despite clinical evidence of impaired hormone-responsive adenylyl cyclase in other tissues, including the kidney. Skeletal responsiveness to PTH may explain the long periods of spontaneous normocalcemia observed in this patient.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770691     DOI: 10.1002/jbmr.5650110103

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Pseudohypoparathyroidism with normocalcemia.

Authors:  N Ozbey
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

2.  Pseudohypoparathyroidism presenting with bony deformities resembling rickets.

Authors:  Anurag Bajpai; Jyoti Sharma; Pankaj Hari; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2004-04       Impact factor: 1.967

Review 3.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

4.  Bone mineral density in pseudohypoparathyroidism type 1a.

Authors:  Dominique N Long; Michael A Levine; Emily L Germain-Lee
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

5.  A novel mutation causing pseudohypoparathyroidism 1A with congenital hypothyroidism and osteoma cutis.

Authors:  Tamar Lubell; Maria Garzon; Kwame Anyane Yeboa; Bina Shah
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-06

Review 6.  Brachydactyly E: isolated or as a feature of a syndrome.

Authors:  Arrate Pereda; Intza Garin; Maria Garcia-Barcina; Blanca Gener; Elena Beristain; Ane Miren Ibañez; Guiomar Perez de Nanclares
Journal:  Orphanet J Rare Dis       Date:  2013-09-12       Impact factor: 4.123

7.  Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.

Authors:  Xiao-Dan Long; Jing Xiong; Zhao-Hui Mo; Chang-Sheng Dong; Ping Jin
Journal:  BMC Med Genet       Date:  2018-07-30       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.